All News
Steatotic Liver Disease: Clear-Cut Liver, Mortality Risks Tied to Subclasses
(MedPage Today) -- Researchers reaffirmed the need to distinguish between steatotic liver disease subtypes, as some could be tied to especially high liver risks in a large retrospective cohort study.
Read MoreSTAT+: Hundreds of NIH grant terminations are ‘void and illegal,’ federal judge rules
A federal judge ruled that some of the grant terminations by the National Institutes of Health on DEI grounds are “void and illegal.
Read MoreBTK Inhibitors for Multiple Sclerosis
(MedPage Today) -- Multiple sclerosis (MS) includes both peripheral and central nervous system (CNS) inflammation, and an anti-inflammatory small molecule therapy that can cross the blood-brain barri
Read MoreAbortion laws in England and Wales face biggest shake-up in nearly 60 years
Parliament set to vote on decriminalising abortion, with rival amendments submitted by two Labour MPsParliament is set to vote on whether to decriminalise abortion on Tuesday, in what would be the big
Read MoreSage Therapeutics gets acquired by Maryland drugmaker for up to $795 million
Following a turbulent few years, Sage Therapeutics has been acquired by Maryland-based Supernus Pharmaceuticals for up to $795 million.
Read MoreAdverse Birth Outcomes Tied to Prenatal Exposure to Arsenic in Public Water
(MedPage Today) -- Prenatal exposure to arsenic in public water even below federally regulated levels was linked with some adverse birth outcomes, a cohort study found.
Read MoreGLP-1 Drugs May Help in Fibromyalgia, Large Records Study Suggests
(MedPage Today) -- BARCELONA -- A rheumatology trainee who went on TikTok to find information on her own condition may have uncovered a novel and possibly tectonic approach to treating fibromyalgia
Read MoreSupreme Court to Hear Case on Subpoena to Anti-Abortion Pregnancy Centers
The question for the justices is whether the centers may pursue a First Amendment challenge to a state subpoena seeking donor information in federal court.
Read MoreMonotherapy for CLL
(MedPage Today) -- Many patients with chronic lymphocytic leukemia (CLL) are treated with two- or three-drug regimens, but for some patients just one drug may be enough.
Read MoreSTAT+: Private equity firm will finance Harvard research lab, in possible template for future
A private equity firm will finance a Harvard University research lab, a possible template for the future as schools nationwide absorb federal funding cuts.
Read More